Capitalism, Innovations, and Health after Covid-19

Sébastien Lechevalier is Professor of Economics at EHESS, Paris, specializing in Japanese economy and Asian capitalism. His research focuses on innovation systems and socio-economic transformations. He is author of The Great Transformation of Japanese Capitalism and editor of Innovation Beyond Technology. He leads major international projects on care-led innovation and institutional change in Asia.Jean-Paul Gaudillière is Senior Researcher at Inserm and Professor at EHESS. A historian of science and medicine, his work examines pharmaceutical capitalism, health governance, and global health politics. His recent books include Global Health and the New World Order and Global Health for All.Kathryn Ibata-Arens is Vincent de Paul Professor of Political Economy and Endowed Professor of Environmental Diplomacy at DePaul University. Her research addresses innovation and entrepreneurship in Asia, biomedical policy, and responsible innovation. Ibata-Arens is the author of Pandemic Medicine and Beyond Technonationalism, and co-founded the Health Network of the Society for the Advancement of Socio-Economics (SASE).Kayo Takuma is Professor of International Politics at Keio University. Her research focuses on global health governance and Asian regional health cooperation. She has published widely on health diplomacy and international political order and served on G7 global health working groups.

• Chapter 1: Capitalism, innovations, and health after Covid-19. An Asian perspective: an introduction.- Part I - Systems in crisis? Capitalism, innovation and health: Chapter 2: Anthropogenetic development: Long unnoticed and already in crisis.- Chapter 3: The crisis of capitalism and health innovation: symptoms of a crisis or of success?.- Chapter 4: The Mission Oriented Science, Innovation and Technology (STI) Policies in Japan and Korea with a Focus on Health.- Part II – A critical moment and its openings: Covid responses: Chapter 5: Innovation Systems under Crisis: Vaccine Development in Asia and Europe.- Chapter 6: Glocal Health Governance: Organizational Innovations in the Era of Covid-19.- Chapter 7: Frugal Innovations and Health System Resilience. The conceptualization, policy support and forms of frugality during Covid-19 in South India.- Part III – Knowledge in action: Asian experiences: Chapter 8: Institutional design, welfare technologies and diffusion of innovation: Stakeholders’ views regarding care robots in Hong Kong SAR (China), Ireland and Japan.- Chapter 9: Care-led innovation. A new paradigm and an application in the Japanese context of Society 5.0.- Chapter 10: Appropriate technologies, primary health care and the integration of traditional medicines in India.- Chapter 11: Commons and the political economy of access: generics, neo traditional formulations and the dominant intellectual property regime of medicines.- Chapter 12: General conclusion.